Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Ceritinib-d7
Price: Check
Purity: 99.0%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

1632484-77-5

1632484-77-5 structure

1632484-77-5 structure

Name: Ceritinib-d7
Chemical Name: Ceritinib D7
CAS Number: 1632484-77-5
Molecular Formula: C₂₈H₂₉D₇ClN₅O₃S
Molecular Weight: 565.18
Catalog: Signaling Pathways Protein Tyrosine Kinase/RTK ALK
Create Date: 2020-01-23 11:17:51
Modify Date: 2024-01-22 21:38:45
Ceritinib D7 (LDK378 D7) is a deuterium labeled Ceritinib. Ceritinib is a selective, orally bioavailable and ATP-competitive ALK tyrosine kinase inhibitor[1].

Name	Ceritinib D7

Description	Ceritinib D7 (LDK378 D7) is a deuterium labeled Ceritinib. Ceritinib is a selective, orally bioavailable and ATP-competitive ALK tyrosine kinase inhibitor[1].
Related Catalog	Research Areas >> Cancer Research Areas >> Endocrinology Signaling Pathways >> Protein Tyrosine Kinase/RTK >> ALK Signaling Pathways >> Protein Tyrosine Kinase/RTK >> IGF-1R Signaling Pathways >> Protein Tyrosine Kinase/RTK >> Insulin Receptor
References	[1]. Marsilje TH, et al. Synthesis, structure-activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (ALK) inhibitor 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) currently in phase 1 and phase 2 clinical trials. J Med Chem. 2013 Jul 25;56(14):5675-90.

Molecular Formula	C₂₈H₂₉D₇ClN₅O₃S
Molecular Weight	565.18

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.